CY1114532T1 - (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα - Google Patents

(2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα

Info

Publication number
CY1114532T1
CY1114532T1 CY20131100949T CY131100949T CY1114532T1 CY 1114532 T1 CY1114532 T1 CY 1114532T1 CY 20131100949 T CY20131100949 T CY 20131100949T CY 131100949 T CY131100949 T CY 131100949T CY 1114532 T1 CY1114532 T1 CY 1114532T1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical compositions
compositions containing
aminofinyl
propanamides
sulphonyl
Prior art date
Application number
CY20131100949T
Other languages
English (en)
Inventor
Marcello Allegretti
Riccardo Bertini
Cinzia Bizzarri
Maria Candida Cesta
Andrea Aramini
Alessio Moriconi
Original Assignee
Dompe' S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe' S.P.A. filed Critical Dompe' S.P.A.
Publication of CY1114532T1 publication Critical patent/CY1114532T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με καινοφανή (2R)-2-φαινυλπροπαναμίδια φέροντας ένα υποκατάστατο 4-σουλφονυλαμινομάδας επί της θέσης 4 της φαινυλομάδας, και με φαρμακευτικές συνθέσεις περιέχοντας τα, τα οποία χρησιμοποιούνται ως αναστολείς της χημειοταξίας των πολυμορφοπύρηνων και μονοπύρηνων κυττάρων και τα οποία είναι χρήσιμα στην αγωγή διαφόρων μεσολαβούμενων από τις χημειοκίνες ΕLR+CΧC διαταραχών. Ειδικότερα δε, οι ενώσεις της εφεύρεσης είναι χρήσιμες στην αγωγή και τον έλεγχο συγκεκριμένων εξαρτώμενων από τον CΧCR2 παθολογιών όπως είναι το ΒΟS, ή COPD, η αγγειογένεση και το μελάνωμα.
CY20131100949T 2006-05-18 2013-10-25 (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα CY1114532T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114185 2006-05-18
EP07729254.8A EP2024329B1 (en) 2006-05-18 2007-05-17 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CY1114532T1 true CY1114532T1 (el) 2016-10-05

Family

ID=38353147

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100949T CY1114532T1 (el) 2006-05-18 2013-10-25 (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα

Country Status (23)

Country Link
US (2) US7652169B2 (el)
EP (1) EP2024329B1 (el)
JP (1) JP5161873B2 (el)
KR (1) KR101422299B1 (el)
CN (1) CN101448784B (el)
AU (1) AU2007253424B2 (el)
BR (1) BRPI0712064B8 (el)
CA (1) CA2649794C (el)
CY (1) CY1114532T1 (el)
DK (1) DK2024329T3 (el)
ES (1) ES2433095T3 (el)
HK (1) HK1131380A1 (el)
HR (1) HRP20130989T1 (el)
IL (1) IL194939A (el)
MX (1) MX2008013957A (el)
NZ (1) NZ572075A (el)
PL (1) PL2024329T3 (el)
PT (1) PT2024329E (el)
RS (1) RS53007B (el)
RU (1) RU2457201C2 (el)
SI (1) SI2024329T1 (el)
WO (1) WO2007135080A2 (el)
ZA (1) ZA200808907B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
KR101298651B1 (ko) * 2011-03-16 2013-08-21 연세대학교 산학협력단 효능이 강화된 혈관신생 억제용 약제학적 조성물
CN103159674A (zh) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途
EP3011012B1 (en) 2013-06-18 2018-09-12 New York University Cellular factors involved in the cytotoxicity of staphylococcus aureus leukocidins: novel therapeutic targets
JP2017527542A (ja) * 2014-07-31 2017-09-21 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 化学療法誘発末梢神経障害（ｃｉｐｎ）の予防および／または治療のためのｃｘｃｒ２アンタゴニストの使用
EP3884932A1 (en) 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
BR112022018294A2 (pt) 2020-03-26 2023-01-10 Dompe Farm Spa Inibidores de cxcl8 para uso no tratamento de covid-19

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188162B (el) * 1999-02-05 2002-08-31 Torrent Pharmaceuticals Ltd
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
SI1776336T1 (sl) * 2004-03-23 2010-01-29 Dompe Spa Derivati 2-fenilpropionske kisline in farmacevtski sestavki, ki jih vsebujejo
NZ555502A (en) * 2004-12-15 2010-12-24 Dompe Pha R Ma Spa Res & Mfg 2-arylpropionic acid derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA2649794A1 (en) 2007-11-29
US20090093530A1 (en) 2009-04-09
EP2024329B1 (en) 2013-07-31
US7868046B2 (en) 2011-01-11
IL194939A (en) 2015-02-26
EP2024329A2 (en) 2009-02-18
HK1131380A1 (en) 2010-01-22
JP2010505742A (ja) 2010-02-25
DK2024329T3 (da) 2013-11-04
MX2008013957A (es) 2008-11-14
CA2649794C (en) 2016-02-16
BRPI0712064B1 (pt) 2020-10-20
WO2007135080A3 (en) 2008-01-10
US7652169B2 (en) 2010-01-26
CN101448784B (zh) 2012-07-04
SI2024329T1 (sl) 2014-01-31
ZA200808907B (en) 2010-03-31
PL2024329T3 (pl) 2014-03-31
AU2007253424A1 (en) 2007-11-29
RU2008149936A (ru) 2010-06-27
JP5161873B2 (ja) 2013-03-13
NZ572075A (en) 2011-11-25
RU2457201C2 (ru) 2012-07-27
RS53007B (en) 2014-04-30
AU2007253424B2 (en) 2013-03-07
KR101422299B1 (ko) 2014-07-22
CN101448784A (zh) 2009-06-03
BRPI0712064A2 (pt) 2011-12-20
IL194939A0 (en) 2009-08-03
US20100152256A1 (en) 2010-06-17
WO2007135080A2 (en) 2007-11-29
HRP20130989T1 (hr) 2013-12-06
ES2433095T3 (es) 2013-12-09
KR20090010979A (ko) 2009-01-30
PT2024329E (pt) 2013-11-04
BRPI0712064B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
CY1114532T1 (el) (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα
SE0101675D0 (sv) Novel composition
SE0202241D0 (sv) Novel Compounds
CY1118658T1 (el) Συνθεση 18f-ραδιοεπισημασμενων στυρυλοπυριδινων απο τοσυλικες προδρομες ενωσεις και σταθερες φαρμακευτικες συνθεσεις αυτων
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
BR0206968A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como antagonistas receptores de quimiocina cxc
CY1119077T1 (el) Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
SE0302232D0 (sv) Novel Compounds
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
SE0301372D0 (sv) Novel compounds
MY153719A (en) Prokineticin 1 receptor antagonists
CY1109232T1 (el) Νεα καρβαμυλιωμενη ερο και μεθοδος παραγωγης της
ATE433447T1 (de) Pyrimiidinverbindungen
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CY1113617T1 (el) Νεα παραγωγα φαινυλαμινοπυριμιδινης ως αναστολεις της κινασης bcr-abl
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
DK1474425T3 (da) Deazapuriner og anvendelser deraf
SE0403006D0 (sv) New compounds
GB0524814D0 (en) Compounds
SE0302139D0 (sv) Novel compounds
CY1113257T1 (el) Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
TW200745039A (en) Isotopically substituted pantoprazole